Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Laura on +44 1494 818 026 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Laura Marsh
Account Manager
+44 1494 818 026

I contacted Zenopa again after a number of years, they took the time to explore what my needs were and suggested a few jobs they were recruiting for.
Bhavna, 2011

Merck Sharpe and Dohme to assist in African Aids initiative

25 August 2010 00:00 in Pharmaceutical Company Product News

Merck Sharpe and Dohme has committed to increasing its financial support for a campaign to combat the spread of Aids and HIV in the African nation of Botswana.

In association with the Bill and Melinda Gates Foundation, the firm's Merck Foundation unit will provide an additional $60 million (38.9 million pounds) for Botswana's African Comprehensive HIV/AIDS Partnerships (ACHAP).

By donating extra money to the public-private partnership, Merck Sharpe and Dohme will be helping to meet the care and treatment needs of disease sufferers in the nation, while it is also contributing HIV medicines.

In total, the Merck Foundation and Gates Foundation have provided $166.5 million in support of ACHAP.

Richard Clark, chairman and chief executive officer of Merck Sharpe and Dohme, said: "This collaboration is a great success story on many levels and has become a model for many countries both on and off the African continent."

This comes after it was announced earlier this month that Merck Sharpe and Dohme is to partner with Project Hope to provide pneumococcal disease vaccinations for patients in Nicaragua.ADNFCR-8000103-ID-800039032-ADNFCR

Other news stories from 25/08/2010

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd